Literature DB >> 1687690

Reversal of neuromuscular blockade in humans by neostigmine and edrophonium: a mathematical model.

D Verotta1, J Kitts, R Rodriguez, J Coldwell, R D Miller, L B Sheiner.   

Abstract

Generalizations of the integrated model describing the interaction of nondepolarizing neuromuscular blocking drugs with reversible anticholinesterase drugs described in Unadkat et al. (1) are reported. The models can deal with possible incomplete reversal (irreversible block) and/or noninstantaneous anticholinesterase kinetics. Experimental data were obtained from 22 human volunteers. Different levels of steady-state vecuronium block were induced in each volunteer (in the range of 50% to 95%), and reversed by short infusions of edrophonium (10 volunteers) or neostigmine (12 volunteers). Edrophonium or neostigmine concentrations and twitch tension (measured as the force of thumb adduction) were measured. The generalized integrated models fit the data well. In the case of neostigmine we find a nondistributional delay in its action. We relate this delay to the slow decarbamylation rate of the (neostigmine-induced) carbamylated anticholinesterase observed in vitro, and are able to model such noninstantaneous anticholinesterase kinetic processes. For both edrophonium and neostigmine we detect an inverse relationship between the (induced) level of initial block and maximal percentage recovery.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1687690     DOI: 10.1007/bf01080875

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  8 in total

1.  The interaction of tensilon and neostigmine with acetylcholinesterase.

Authors:  I B WILSON
Journal:  Arch Int Pharmacodyn Ther       Date:  1955-12-01

2.  Quantitation of pancuronium, 3-desacetylpancuronium, vecuronium, 3-desacetylvecuronium, pipecuronium and 3-desacetylpipecuronium in biological fluids by capillary gas chromatography using nitrogen-sensitive detection.

Authors:  T Furuta; P C Canfell; K P Castagnoli; M L Sharma; R D Miller
Journal:  J Chromatogr       Date:  1988-05-13

3.  Antagonism of d-tubocurarine- and pancuronium-induced neuromuscular blockades by pyridostigmine in man.

Authors:  R P Fogdall; R D Miller
Journal:  Anesthesiology       Date:  1973-11       Impact factor: 7.892

4.  Kinetics of interaction between drugs and biological systems.

Authors:  G Segre
Journal:  Farmaco Sci       Date:  1968-10

5.  Reversed-phase, ion-pair liquid chromatography of quaternary ammonium compounds: determination of pyridostigmine, neostigmine and edrophionium in biological fluids.

Authors:  M G De Ruyter; R Cronnelly
Journal:  J Chromatogr       Date:  1980-08-08

6.  An integrated model for the interaction of muscle relaxants with their antagonists.

Authors:  J D Unadkat; L B Sheiner; P J Hennis; R Cronnelly; R D Miller; M Sharma
Journal:  J Appl Physiol (1985)       Date:  1986-10

7.  Edrophonium: duration of action and atropine requirement in humans during halothane anesthesia.

Authors:  R Cronnelly; R B Morris; R D Miller
Journal:  Anesthesiology       Date:  1982-10       Impact factor: 7.892

8.  Phenyldichlorophosphate as an aid in studies of decarbamylation of carbamylated acetylcholinesterase.

Authors:  R M Dawson; M Poretski
Journal:  Anal Biochem       Date:  1988-05-01       Impact factor: 3.365

  8 in total
  2 in total

Review 1.  Pharmacokinetic-pharmacodynamic modelling in anaesthesia.

Authors:  Pedro L Gambús; Iñaki F Trocóniz
Journal:  Br J Clin Pharmacol       Date:  2015-01       Impact factor: 4.335

2.  Pharmacodynamic analysis of contractile potentiation by cholinesterase inhibitors in rats.

Authors:  K Yamamoto; Y Sawada; T Iga
Journal:  J Pharmacokinet Biopharm       Date:  1996-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.